Advertisement
Advertisement
BCRX
BioCryst Pharmaceuticals Inc
9.12
USDSponsored
+0.13
+1.43%
Apr 30, 10:13 UTC -4
Open
BCRX Earnings Reports
Positive Surprise Ratio
BCRX beat 22 of 41 last estimates.
54%
Next Report
Next Week
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$154.15M
/$0.04
Implied change from Q4 25 (Revenue/ EPS)
-5.19%
/+300.00%
Implied change from Q1 25 (Revenue/ EPS)
+5.92%
/--
BioCryst Pharmaceuticals Inc earnings per share and revenue
On Feb 26, 2026, BCRX reported earnings of 0.01 USD per share (EPS) for Q4 25, missing the estimate of 0.03 USD, resulting in a -74.09% surprise. Revenue reached 162.57 million, compared to an expected 152.63 million, with a 6.51% difference. The market reacted with a -4.80% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of 0.04 USD, with revenue projected to reach 154.15 million USD, implying an increase of 300.00% EPS, and decrease of -5.19% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amneal Pharmaceuticals, Inc. Class A Common Stock
Report Date
Apr 22, 2026 For Q1 26
Estimate
$0.17
Actual
$0.27
Surprise
+55.71%
Indivior Pharmaceuticals, Inc. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.66
Actual
$0.96
Surprise
+43.69%
Ionis Pharmaceuticals, Inc. Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.92
Actual
-$0.30
Surprise
+67.55%
FAQ
What were BioCryst Pharmaceuticals Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, BioCryst Pharmaceuticals Inc reported EPS of $0.01, missing estimates by -74.09%, and revenue of $162.57M, 6.51% above expectations.
How did the market react to BioCryst Pharmaceuticals Inc's Q4 2025 earnings?
The stock price moved down -4.8%, changed from $7.09 before the earnings release to $6.75 the day after.
When is BioCryst Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for BioCryst Pharmaceuticals Inc's next earnings report?
Based on 6
analysts, BioCryst Pharmaceuticals Inc is expected to report EPS of $0.04 and revenue of $154.15M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement